FOR IMMEDIATE RELEASE REDWOOD CITY, CALIF – March 3, 2025: Osteoboost Health Inc. today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 12,232,993 for Osteoboost, the first FDA-cleared wearable device designed to treat osteopenia and improve bone health through targeted vibration therapy, and…
Read more
First-of-its-kind FDA-cleared precision vibration therapy wearable device to treat millions at risk of fracture from osteopenia REDWOOD CITY, CALIF – December 4, 2024 – Bone Health Technologies (BHT), a leading medical technology startup developing innovative non-pharmacological solutions to improve bone health and reduce fractures, today announced that pre-orders are now…
Read more
One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly impact quality of life. Our mission with Osteoboost is to slow the process of bone loss and preserve bone density and strength, helping people live stronger,…
Read more
Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company…
Read more
REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more
BHT closes oversubscribed financing round, adds new investors to revolutionize low bone density treatments Redwood City, CA – March 4, 2024 – Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from…
Read more
Redwood City, CA – January 18, 2024 – Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density). Osteoboost is a wearable belt device, worn on the…
Read more
